What is NCEL's relative strength rating?

NCEL ranks at the 21th percentile over 1 month, 66th percentile over 3 months, 81th percentile over 6 months against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is NCEL in?

NCEL is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is NCEL in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). NCEL benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is NCEL?

NCEL currently shows a 20-day average daily range (ADR%) of 7.7%, a 90-day beta versus the S&P 500 of 0.31. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does NCEL have a seasonal pattern?

TickerStance computes NCEL's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NCEL has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did NCEL last report earnings?

No SEC EDGAR filings are linked to NCEL in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

NewcelX Ltd. Ordinary Shares (NCEL) · RS 81

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, NewcelX Ltd. Ordinary Shares (NCEL) has a 3-month relative strength percentile of 66 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.7%, relative volume 0.54×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month66pctile

6 month81pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses lit · avg RS pctile 74

✓ADR%7.7%!A/DC!RVOL0.54×!$ Vol$81K

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

Not enough history to compute monthly seasonality for NCEL.

Evidence · 1 of 3

Receipts behind the read

1 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

21

3m

66

6m

81

1y

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · NCEL

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
NCEL
66RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

ROIVRoivant Sciences Ltd. Common Shares81 AVTXAvalo Therapeutics, Inc. Common Stock81 ZLABZai Lab Limited American Depositary Shares81 RIGLRigel Pharmaceuticals Inc. (New)82

Public attention · NCEL

Is the crowd watching?

53/ 100 · vs its own 90-day norm▲ 17 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float2.4Mshares

Shares out5.7Mshares

Market cap$19.8MNano Cap

FAQ

Frequently asked questions

What is NCEL's relative strength rating?: NCEL ranks at the 21th percentile over 1 month, 66th percentile over 3 months, 81th percentile over 6 months against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is NCEL in?: NCEL is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is NCEL in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). NCEL benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is NCEL?: NCEL currently shows a 20-day average daily range (ADR%) of 7.7%, a 90-day beta versus the S&P 500 of 0.31. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does NCEL have a seasonal pattern?: TickerStance computes NCEL's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NCEL has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

NewcelX Ltd. Ordinary Shares (NCEL) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

NewcelX Ltd. Ordinary Shares (NCEL) — Stance & relative strength

NCEL is not confirmed as a leader. 66 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?